FDA Refreshes Website

Return Home: The Health, Drug, Prescription, and GMP Supersite Blog

SkillsPlus Intl Inc. - GMP Compliance Training Experts
SkillsPlus Intl Info Blog
The Health, Drug, Prescription, and GMP Supersite Gift Store 

CDC Updates To Sexually Transmitted Disease Treatment - Podcast and more

Image via Wikipedia

Updated August 25, 2021

The original links broke.

You can still read about this topic here:

CDC Updates To Sexually Transmitted Diseases - STI Treatment Guidelines

---  the original post follows below  ---

The CDC (Centers for Disease Control and Prevention) updated their guidelines for the treatment of persons who have or are at risk for sexually transmitted diseases (STDs).

For more information, including podcast:   The CDC's 2010 STD Treatment Guidelines website

Read the CDC 2010 STD Treatment Guidelines published in the MMWR (pdf)

Return Home: http://drughealth.blogspot.com/

FDA - New CDRH Event Problem Codes

The FDA just published "CDRH Event Problem Codes. This CDRH website (with enhanced device and patient problem codes) provides you a PREVIEW to the updates that will be going live July 1, 2009. The FDA provides this information in advance to help you familiarize yourselves with Event Problem Code updates BEFORE the new codes ‘go live’ and are accepted in MAUDE. It's important to note that on July 1, 2009 - CDRH will begin accepting the updated codes. DO NOT submit these updated codes prior to that time because they will be rejected. Until that time FDA says to continue to use the current Event Problem Codes. April 2, 2010 is the target date to reject all inactivated and retired codes specified in this FDA update. The CDRH Event Problem Code initiative results in part, with updates to codes to reduce manufacturer reporting burden, improve adverse event report quality, and improve FDA’s ability to respond to device-related adverse events. 

Return Home: http://drughealth.blogspot.com/ 

HHS Updates HIV Treatment Guidelines (free pdf)

Updated March 20, 2023

Get the most recent guidelines:
Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents with HIV - US Dept of HHS

- - -  the original post follows below - - -

A Department of Health and Human Services (HHS) panel has recommended two drug regimens be added to the list of preferred protease-inhibitor components in revised guidelines on the use of antiretrovirals in HIV-1-infected patients. The panel just published their revised guidelines, "
Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Department of Health and Human Services. November 3, 2008; 1-139. These guidelines are intended to help providers make decisions about the use of antiretroviral agents.

It should be noted that these guidelines generally represent the state of knowledge regarding the use of antiretroviral agents. However, as the science rapidly evolves, the availability of new agents and new clinical data may rapidly change therapeutic options and preferences. The guidelines, therefore, are updated frequently by the Panel.

Return Home: http://drughealth.blogspot.com/